Getacatetide

N/A

Report date: 2026/03/12 20:00:16
NMEFirst In Class

Base Information

Drug NameGetacatetide
Drug Alias NameCyPep-1CyPep-H1CY-101
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionWnt signalling pathway inhibitors
TargetsUpdating
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsItaly +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytovation As
China Registration ClassN/A

Develop Information

Active CompaniesCytovation As
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsBreast Neoplasms +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A